A Review of Efficacy and Safety of Checkpoint Inhibitor for the Treatment of Acute Myeloid Leukemia
Immune checkpoint inhibitors (ICIs) as positive modulators of immune response have revolutionized the treatment of cancer and have achieved impressive efficacy in melanoma and numerous solid tumor malignancies. These agents are being investigated in acute myeloid leukemia (AML) to further enhance re...
Saved in:
Main Authors: | Dan Liao (Author), Mengyao Wang (Author), Yi Liao (Author), Jun Li (Author), Ting Niu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preclinical evaluation of the ROCK1 inhibitor, GSK269962A, in acute myeloid leukemia
by: Ting Pan, et al.
Published: (2022) -
Isocitrate dehydrogenase inhibitors in acute myeloid leukemia
by: Xiaoyan Liu, et al.
Published: (2019) -
Efficacy and safety of oncolytic virus combined with chemotherapy or immune checkpoint inhibitors in solid tumor patients: A meta-analysis
by: Xiangxing Liu, et al.
Published: (2022) -
Acute myeloid leukemia in infants: biology and treatment
by: Riccardo eMasetti, et al.
Published: (2015) -
Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia
by: Juanjuan Zhao, et al.
Published: (2019)